You are here: Home > Cannabinoids (former) > Adulteration of cannabis with tobacco, calamus, and other cholinergic compounds

Cannabinoids 2008;3(4):16-20 (21 December 2008)


Adulteration of cannabis with tobacco, calamus, and other cholinergic compounds

John M. McPartland

Department of Family Medicine, College of Medicine, University of Vermont, Burlington, Vermont, United States,

A shifting demographic of people admix cannabis with cholinergic agents, intent upon enhancing cannabimimetic effects or reducing adverse effects. Augmentation of cannabimimetic effects with tobacco (or nicotine) has been corroborated by in vitro mechanistic studies, animal behaviour stud-ies, anecdotes from patients, and one clinical trial. The mechanism may be pharmacokinetic and pharmacodynamic. This trend of adultering cannabis with tobacco poses a problem because of the adverse effects of tobacco; solutions are suggested. The grey literature also reports admixtures of cannabis and calamus root, with the intent of reducing adverse effects of cannabis. At least one compound in calamus root (beta-asarone) blocks acetylcholinesterase (AChE). Contrary to expectations, AChE blockade diminishes cannabimimetic effects. Obviously more research needs to be done.

Cannabis, endocannabinoid, Nicotiana tabacum, Acorus calamus, nicotinic acetylcholine receptor, muscarinic ACh receptor, acetylcholinesterase

PDF of the full text ]

Online Events 2020

Please find all information of IACM Online Events including free videos of the webinars here.

Virtual Conference 2021

The 12th IACM Conference on Cannabinoids in Medicine will be held online from 14 to 16 October 2021. Registration is for free.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.